The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other ...

The new rule would expand access to the drugs for 3.4 million Americans who use Medicare and another 4 million people ...

Amgen's experimental drug MariTide led to an average weight loss of up to 20% in a year-long mid-stage trial of people who ...

As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid ...

In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...

Here's what doctors thing is behind personality changes caused by Ozempic and other GLP-1s and what you can do about it.

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also ...

The Biden administration is set to propose legislation allowing Medicare and Medicaid to cover the cost of GLP-1 obesity meds ...

Researchers said the drugs could make a major difference for chronic kidney disease patients by helping to reduce other risk ...